Houston-based Security Gate has grown 1,000 percent each year. Getty Images

Cyber security is constantly evolving, and, while information hacks are always a concern, worst-case scenarios could even be life threatening.

Houston-based startup, Security Gate, is addressing all of types of cyber security threats, says Ted Gutierrez, an Army special forces vet and co-founder and CEO of the company.

"It used to be companies were worried about what happens if someone hacks in to your information," he says. "Yes, that's a concern. But now we're talking about cyber attacks that can breach your company, and lives are at stake. We're creating solutions that counter that."

The cyber security firm has, over its last two years of existence, grown steadily — and is poised for future growth.

"We've had a thousand percent growth year by year," says Gutierrez, who credits the company's success to his incremental approach. "We really listened to the market."

When Gutierrez began his company, which helps firms assess risk and discover custom solutions for compliance or performance needs, he set out to capture clients in multiple industries, from oil and gas to defense contractors to the health and educator sectors. Then, SecurityGate collaborated with those clients to find out what was working and what was missing from the firm's approach to its technology. And Gutierrez went back and fixed any issues there were.

"We built our software in four to five months," he says. "And because of the approach we've taken, we didn't have to ever pivot or change the offerings we provided the way some other startups have had to. We've consistently generated revenue since we launched"

Today, SecurityGate counts among its portfolio one of Houston's largest private schools, a defense contractor in the Metroplex, and multiple oil and gas firms. Gutierrez says the company signed what he calls "two monster clients" in 2018, paving the way for his optimistic outlet for this year – and beyond.

The company offers four tiers of service that include one-time individual assessments to long-term solutions that demonstrate a firm's compliance to industry standards, whether they are Fortune 500 organizations or "$5 million companies," he says.

Across 2019, Gutierrez figures he'll add between six and eight employees to the SecurityGate team, which currently numbers about a dozen. That's solid growth for a company that began without angel investors and the help of venture capital firms – although Gutierrez has recently taken meetings with several of those and looks forward to outside investment.

"We really bootstrapped this firm, adding clients and investing that capital in further development," he says.

He's excited by the landscape before him and says he loves Houston's business ecosystem. SecurityGate is a member of Station Houston, and Gutierrez says he loves that larger companies in the city have embraced working with smaller firms like his own. He's encouraged by his firm's growth, and he knows that there's still work in front of the company.

But Gutierrez likens his experience with his start-up to his days in an Army reconnaissance unit.

"I love high-conflict, low-impact settings," he says. "It's you and a few guys and you're in a place for a week and you don't know what you'll find. I love that chaos of jumping out of a plane and right into the job."


This is what a company's Security Gate digital dashboard would look like. Via securitygate.io

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston medtech firm secures $30M for neurosurgical robot

stroke surgery

Robotic neurosurgery is an exciting new frontier in medicine, and Houston-based medtech firm XCath is leading the charge with its revolutionary Iris robotic system. The company announced in March that it had secured $30 million in Series C funding to continue developing systems to tackle blood clots in the human brain.

“We are grateful to our investors for their conviction in our shared mission to improve clinical outcomes for patients impacted by endovascular diseases,” Eduardo Fonseca, CEO of XCath, said in a news release. “In 2025, the XCath team advanced the frontiers of endovascular robotics. This funding accelerates our commitment to expanding access to life-saving care so that where a patient lives no longer determines whether they live.”

XCath–which also has campuses in Pangyo, South Korea–has already achieved a number of remarkable firsts in robotic neurosurgery. The Iris is the only endovascular robotic system currently in development to perform intracranial navigation or neurointerventional treatment, and is the only robot in the world to have performed an intracranial neurovascular procedure involving the robotic manipulation of three devices.

These new Series C funds, which bring the company's total investment to $92 million, will go toward developing a clinical telerobot capable of performing a mechanical thrombectomy. This would bring unprecedented accuracy and precision to the surgical removal of brain clots, significantly reducing the risk of neurosurgery.

“Robotic surgery succeeds when innovation is paired with practical execution,” Dr. Fred Moll, chairman of the XCath board of directors, said in the release. “XCath has built a promising technology foundation, and just as importantly, a team that values rigor and appreciates perspective. I’m excited to support them as they take on the mission of globalizing access to gold-standard care for stroke patients.”

In November 2025, the Iris debuted under the control of Dr. Vitor Mendes Pereira at The Panama Clinic in Panama City, alongside local Principal Investigator Dr. Anastasio Ameijeiras Sibauste. It was only the second time in human history that a robot had been used for intracranial neurovascular intervention, and it established Iris as a viable technology in the fight against stroke.

“Treatment of stroke and other neurovascular diseases represents one of the most significant financial opportunities in healthcare, supported by positive reimbursement dynamics and strong demand from health systems,” Nicholas Drysdale, CFO of XCath, added in the release. “With our continued investor support and disciplined capital deployment, XCath is positioned to build a category-leading platform in endovascular robotics”.

Houston geothermal unicorn Fervo officially files for IPO

going public

Fervo Energy has officially filed for IPO.

The Houston-based geothermal unicorn filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission on April 17 to list its Class A common stock on the Nasdaq exchange. Fervo intends to be listed under the ticker symbol "FRVO."

The number and price of the shares have not yet been determined, according to a news release from Fervo. J.P. Morgan, BofA Securities, RBC Capital Markets and Barclays are leading the offering.

The highly anticipated filing comes as Fervo readies its flagship Cape Station geothermal project to deliver its first power later this year

"Today, miles-long lines for gasoline have been replaced by lines for electricity. Tech companies compete for megawatts to claim AI market share. Manufacturers jockey for power to strengthen American industry. Utilities demand clean, firm electricity to stabilize the grid," Fervo CEO Tim Latimer shared in the filing. "Fervo is prepared to serve all of these customers. Not with complex, idiosyncratic projects but with a simplified, standardized product capable of delivering around-the-clock, carbon-free power using proven oil and gas technology."

Fervo has been preparing to file for IPO for months. Axios Pro first reported that the company "quietly" filed for an IPO in January and estimated it would be valued between $2 billion and $3 billion.

Fervo also closed $421 million in non-recourse debt financing for the first phase of Cape Station last month and raised a $462 million Series E in December. The company also announced the addition of four heavyweights to its board of directors last week, including Meg Whitman, former CEO of eBay, Hewlett-Packard, and Spring-based HPE.

Fervo reported a net loss of $70.5 million for the 2025 fiscal year in the S-1 filing and a loss of $41.1 million in 2024.

Tracxn.com estimates that Fervo has raised $1.12 billion over 12 funding rounds. The company was founded in 2017 by Latimer and CTO Jack Norbeck.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

New UT Austin med center, anchored by MD Anderson, gets $1 billion gift

Future of Health

A donation announced Tuesday, April 21, breaks a major record at the University of Texas at Austin. Michael and Susan Dell are now UT Austin's first supporters to give $1 billion. In response, the university will create the UT Dell Campus for Advanced Research and the UT Dell Medical Center to "advance human health," per a press release.

The release also records "significant support" for undergraduate scholarships, student housing, and the Texas Advanced Computing Center for supercomputing research.

Both the new research campus and the UT Dell Medical Center will integrate advanced computing into their research and practices. At the medical center, the university hopes that will lead to "earlier detection, more precise and personalized care, and better health outcomes." The University of Texas MD Anderson Cancer Center will also be integrated into the new medical center.

That comes with a numeric goal measured in 10s: raise $10 billion and rank among the top 10 medical centers in the U.S., both in the next decade.

In the shorter term, the university will break ground on the medical center with architecture firm Skidmore, Owings & Merrill (SOM) "later this year."

“UT Austin, where Dell Technologies was founded from a dorm room, has always been a place where bold ideas become real-world impact,” said Michael and Susan Dell in a joint statement.

They continued, “What makes this moment so meaningful is the opportunity to build something that brings every part of the journey together — from how students learn, to how discoveries are made, to how care reaches families. By bringing together medicine, science and computing in one campus designed for the AI era, UT can create more opportunity, deliver better outcomes, and build a stronger future for communities across Texas and beyond.”

This is the second major gift this year for the planned multibillion-dollar medical center. In January, Tench Coxe, a former venture capitalist who’s a major shareholder in chipmaking giant Nvidia, and Simone Coxe, co-founder and former CEO of the Blanc & Otus PR firm, contributed $100 million$100 million.